BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22776707)

  • 1. Centralised multidisciplinary re-evaluation of diagnostic procedures in patients with newly diagnosed Hodgkin lymphoma.
    Stevens WBC; van Krieken JH; Mus RDM; Arens AIJ; Mattijssen V; Oosterveld M; de Kruijf EJFM; de Vries F; Koster A; van der Maazen R; Raemaekers J
    Ann Oncol; 2012 Oct; 23(10):2676-2681. PubMed ID: 22776707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma.
    Pinczés L; Miltényi Z; Illés Á
    J Cancer Res Clin Oncol; 2018 May; 144(5):935-943. PubMed ID: 29468437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin lymphoma in Tyrol-a population-based study.
    Fong D; Steurer M; Greil R; Gunsilius E; Spizzo G; Gastl G; Tzankov A
    Ann Hematol; 2009 May; 88(5):449-56. PubMed ID: 18846373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Hodgkin lymphoma.
    Ansell SM; Armitage JO
    Mayo Clin Proc; 2006 Mar; 81(3):419-26. PubMed ID: 16529147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.
    Sasse S; Bröckelmann PJ; Goergen H; Plütschow A; Müller H; Kreissl S; Buerkle C; Borchmann S; Fuchs M; Borchmann P; Diehl V; Engert A
    J Clin Oncol; 2017 Jun; 35(18):1999-2007. PubMed ID: 28418763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group.
    Bröckelmann PJ; Goergen H; Fuchs M; Kriz J; Semrau R; Baues C; Kobe C; Behringer K; Eichenauer DA; von Tresckow B; Klimm B; Halbsguth T; Wongso D; Plütschow A; Haverkamp H; Dietlein M; Eich HT; Stein H; Diehl V; Borchmann P; Engert A
    Br J Haematol; 2015 Nov; 171(4):547-56. PubMed ID: 26310520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the initial management of Hodgkin's Lymphoma.
    Marri PR; Ansell SM
    Transfus Apher Sci; 2013 Aug; 49(1):12-8. PubMed ID: 23769695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
    Milgrom SA; Jauhari S; Plastaras JP; Nieto Y; Dabaja BS; Pinnix CC; Smith GL; Allen PK; Lukens JN; Maity A; Oki Y; Fanale MA; Nasta SD
    Cancer; 2017 Apr; 123(8):1363-1371. PubMed ID: 27984652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy.
    Pinnix CC; Osborne EM; Chihara D; Lai P; Zhou S; Ramirez MM; Oki Y; Hagemeister FB; Rodriguez AM; Samaniego F; Fowler N; Romaguera JE; Turturro F; Fayad L; Westin JR; Nastoupil L; Neelapu SS; Cheah CY; Dabaja BS; Milgrom SA; Smith GL; Horace P; Milbourne A; Wogan CF; Ballas L; Fanale MA
    JAMA Oncol; 2016 Aug; 2(8):1065-9. PubMed ID: 27227654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Reported Survivorship Care Practices and Late Effects After Treatment of Hodgkin and Non-Hodgkin Lymphoma.
    Frick MA; Vachani CC; Hampshire MK; Bach C; Arnold-Korzeniowski K; Metz JM; Hill-Kayser CE
    JCO Clin Cancer Inform; 2018 Dec; 2():1-10. PubMed ID: 30652594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of 135 newly diagnosed patients with Hodgkin lymphoma].
    Zhou J; Wu X; Dai Y; Liu T; Xu C
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):304-8. PubMed ID: 24759017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable early-stage Hodgkin lymphoma.
    Yahalom J
    J Natl Compr Canc Netw; 2006 Mar; 4(3):233-40. PubMed ID: 16507270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte-predominant Hodgkin lymphoma--clinical features and treatment outcomes from a 30-year experience.
    Jackson C; Sirohi B; Cunningham D; Horwich A; Thomas K; Wotherspoon A
    Ann Oncol; 2010 Oct; 21(10):2061-2068. PubMed ID: 20332141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma.
    Pinnix CC; Smith GL; Milgrom S; Osborne EM; Reddy JP; Akhtari M; Reed V; Arzu I; Allen PK; Wogan CF; Fanale MA; Oki Y; Turturro F; Romaguera J; Fayad L; Fowler N; Westin J; Nastoupil L; Hagemeister FB; Rodriguez MA; Ahmed S; Nieto Y; Dabaja B
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):175-82. PubMed ID: 25863764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.
    Rueda Domínguez A; Alfaro Lizaso J; de la Cruz Merino L; Gumá I Padró J; Quero Blanco C; Gómez Codina J; Llanos Muñoz M; Martinez Banaclocha N; Rodriguez Abreu D; Provencio Pulla M
    Clin Transl Oncol; 2015 Dec; 17(12):1005-13. PubMed ID: 26497354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study.
    Lazarovici J; Dartigues P; Brice P; Obéric L; Gaillard I; Hunault-Berger M; Broussais-Guillaumot F; Gyan E; Bologna S; Nicolas-Virelizier E; Touati M; Casasnovas O; Delarue R; Orsini-Piocelle F; Stamatoullas A; Gabarre J; Fornecker LM; Gastinne T; Peyrade F; Roland V; Bachy E; André M; Mounier N; Fermé C
    Haematologica; 2015 Dec; 100(12):1579-86. PubMed ID: 26430172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen.
    Picardi M; Soricelli A; Grimaldi F; Nicolai E; Gallamini A; Pane F
    Ann Oncol; 2011 Mar; 22(3):671-680. PubMed ID: 20693297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules.
    Kampers J; Orjuela-Grimm M; Schober T; Schulz TF; Stiefel M; Klein C; Körholz D; Mauz-Körholz C; Kreipe H; Beier R; Maecker-Kolhoff B
    Leuk Lymphoma; 2017 Mar; 58(3):633-638. PubMed ID: 27685149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network.
    Farrell K; McKay P; Leach M
    Leuk Lymphoma; 2011 Oct; 52(10):1920-8. PubMed ID: 21663507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.